Valneva

Valneva is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases, addressing unmet medical needs. The company has successfully commercialized several vaccines, including the world’s first and only chikungunya vaccine, and continues to advance a pipeline of vaccine candidates covering diseases such as Lyme disease, Shigella, and Zika. Valneva leverages its expertise in vaccine research and development to address significant global health challenges.